Alphina Therapeutics
AI Healthcare
precision oncology / cancer therapeutics
Series A
Alphina Therapeutics is a private biotechnology company focused on precision oncology, developing NAMPT inhibitor-based antibody-drug conjugates (ADCs) and a proprietary companion diagnostic to identify patients most likely to benefit from its therapies.
Company Details
- Website
- alphinatx.com
- Headquarters
- New Haven, Connecticut, United States
- Founded
- 2020
- Funding
- $40M
Subscriber Intelligence
- • Deal signal alerts for this company
- • Sentiment & risk scoring
- • Competitive framework analysis
- • Regulatory event monitoring